PULSE REDUCTION IN MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY (TWO CLINICAL CASES)
Two clinical cases presented, of the patients with hypertrophic cardiomyopathy and individualized pulse reduction therapy approach. Patients were prescribed consequently bisoprolol and ivabradine (Coraxan®, “Les Laboratoires Servier”, France) with comparative efficacy assessment by a complex investi...
Saved in:
Main Authors: | N. S. Krylova, E. A. Kovalevskaya, N. G. Poteshkina, Е. A. Mershina, V. Е. Sinitsyn, N. A. Sonicheva, L. Monserrat |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2017-12-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2603 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2010-02-01) -
Echocardiographic predictors of outcomes in hypertrophic cardiomyopathy
by: Annamaria Del Franco, et al.
Published: (2023-10-01) -
CHRONIC HEART FAILURE IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: N. S. Krylova, et al.
Published: (2011-04-01) -
ATRIAL FIBRILLATION AND FLUTTER IN HYPERTROPHIC CARDIOMYOPATHY
by: N. S. Krylova, et al.
Published: (2015-05-01) -
SUDDEN DEATH IN HYPERTROPHIC CARDIOMYOPATHY: SEARCH FOR NEW RISK FACTORS
by: N. S. Krylova, et al.
Published: (2017-02-01)